Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
In the realm of pharmaceutical synthesis, chirality plays a pivotal role. The specific three-dimensional arrangement of atoms in a molecule can dramatically influence its biological activity, efficacy, and safety. Chiral building blocks, such as Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric acid (CAS: 269396-59-0), are essential for constructing enantiomerically pure drug candidates. As a specialized manufacturer, we provide these vital chiral intermediates to support the advancement of medicinal chemistry and drug development.
The Crucial Role of Chirality in Pharmaceuticals
Many drug targets within the human body, such as enzymes and receptors, are themselves chiral. Consequently, they can interact differently with the enantiomers of a chiral drug molecule. One enantiomer might be therapeutically active, while the other could be inactive, less effective, or even toxic. The thalidomide tragedy in the 1960s starkly highlighted the importance of developing and producing single-enantiomer drugs. Regulatory bodies worldwide now mandate the development of chiral drugs in their pure enantiomeric form whenever possible, making access to reliable chiral building blocks indispensable for pharmaceutical manufacturers and researchers.
Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric Acid: A Versatile Chiral Intermediate
Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric acid is a prime example of a valuable chiral building block. Its specific (R) configuration, combined with the protective Boc group and the 3,4-difluorophenyl moiety, makes it a powerful tool for chemists.
These attributes make it a preferred intermediate for developing new drug candidates targeting a variety of diseases.
Sourcing High-Quality Chiral Building Blocks
Given the critical nature of chirality in drug efficacy, sourcing chiral building blocks like Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric acid requires a high degree of confidence in the supplier. As a dedicated manufacturer, we understand the stringent quality requirements of the pharmaceutical industry. We ensure that our Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric acid is produced with high enantiomeric purity and exceptional chemical purity (≥97%), guaranteeing batch-to-batch consistency. Our manufacturing processes in China are geared towards producing these advanced intermediates reliably and affordably.
Partner with a Trusted Supplier
For pharmaceutical companies and research institutions, securing a dependable supply of chiral intermediates is vital. We invite you to buy Boc-(R)-3-Amino-4-(3,4-difluorophenyl)butyric acid from us and experience the benefits of partnering with a quality-focused manufacturer. Our commitment to excellence, competitive pricing, and responsive customer support makes us an ideal partner for your pharmaceutical synthesis needs. Contact us today to learn more about our products and how we can support your research and production requirements.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
